Chronic Lymphocytic Leukemia and Transplantation
The CLL channel on VJHemOnc.com is sponsored by Janssen Pharmaceuticals, AbbVie Ltd and BeiGene Ltd. The companies have no influence over the production of the content
Regulatory qualification for the EBMT patient registry for CAR T-cell therapy
The success story of indolent disease treatment expanded to difficult-to-treat patient groups
What are the benefits of having different chronic lymphocytic leukemia (CLL) treatment options?
Transplantation versus novel therapies in high-risk chronic lymphoblastic leukemia (CLL)?